Correlation Between Intracellular and Instadose Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intracellular and Instadose Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intracellular and Instadose Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intracellular Th and Instadose Pharma Corp, you can compare the effects of market volatilities on Intracellular and Instadose Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intracellular with a short position of Instadose Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intracellular and Instadose Pharma.

Diversification Opportunities for Intracellular and Instadose Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Intracellular and Instadose is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Intracellular Th and Instadose Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Instadose Pharma Corp and Intracellular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intracellular Th are associated (or correlated) with Instadose Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Instadose Pharma Corp has no effect on the direction of Intracellular i.e., Intracellular and Instadose Pharma go up and down completely randomly.

Pair Corralation between Intracellular and Instadose Pharma

If you would invest  7,266  in Intracellular Th on September 4, 2024 and sell it today you would earn a total of  1,337  from holding Intracellular Th or generate 18.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Intracellular Th  vs.  Instadose Pharma Corp

 Performance 
       Timeline  
Intracellular Th 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Intracellular Th are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Intracellular demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Instadose Pharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Instadose Pharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Instadose Pharma is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Intracellular and Instadose Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intracellular and Instadose Pharma

The main advantage of trading using opposite Intracellular and Instadose Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intracellular position performs unexpectedly, Instadose Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Instadose Pharma will offset losses from the drop in Instadose Pharma's long position.
The idea behind Intracellular Th and Instadose Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences